Pneumococcal Infection
31
1
1
24
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
3.2%
1 terminated out of 31 trials
96.0%
+9.5% vs benchmark
45%
14 trials in Phase 3/4
42%
10 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (31)
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013)
Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)
Opportunistic Pneumococcal Immunisation Trial in MALnutrition
Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)
The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants
Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3)
Safety, Tolerability, and Immunogenicity of a Polyvalent Pneumococcal Conjugate Vaccine (V116) in Japanese Adults (V116-002)
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy Volunteers
Aerosolized and Intravenous Colistin in Healthy Adults
A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy Infants
Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)
Systems Biology of PNEUMOVAX®23 and PREVNAR 13®
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects
A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults
Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan
ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)
Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007)
Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia